In Vitro Activity of LYS228, a Novel Monobactam Antibiotic, against Multidrug-Resistant Enterobacteriaceae

Lignende værker

• Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae
  af: Dean, Charles R., et al.
  Udgivet: (2018)
• Impact of Inducible bla(DHA-1) on Susceptibility of Klebsiella pneumoniae Clinical Isolates to LYS228 and Identification of Chromosomal mpl and ampD Mutations Mediating Upregulation of Plasmid-Borne bla(DHA-1) Expression
  af: Jones, Adriana K., et al.
  Udgivet: (2018)
• A First-in-Human Study To Assess the Safety and Pharmacokinetics of LYS228, a Novel Intravenous Monobactam Antibiotic in Healthy Volunteers
  af: Osborn, Megan, et al.
  Udgivet: (2019)
• In Vivo Efficacy of Novel Monobactam LYS228 in Murine Models of Carbapenemase-Producing Klebsiella pneumoniae Infection
  af: Weiss, W. J., et al.
  Udgivet: (2019)
• Identification of Mutations in the mrdA Gene Encoding PBP2 That Reduce Carbapenem and Diazabicyclooctane Susceptibility of Escherichia coli Clinical Isolates with Mutations in ftsI (PBP3) and Which Carry bla(NDM-1)
  af: Ranjitkar, Srijan, et al.
  Udgivet: (2019)